Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury

Mukesh Jain, Qi He, Wen Sen Lee, Saori Kashiki, Lauren C. Foster, Jer Chia Tsai, Mu En Lee, Edgar Haber

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

CD44, the principal receptor for hyaluronic acid, is a widely distributed cell surface proteoglycan involved in cellular activation, proliferation, and migration. These processes are also central to the vascular smooth muscle cell's response to arterial wall injury. We evaluated the expression of CD44 and its isoform, CD44-v6, on vascular smooth muscle cells in vitro and in vivo and assessed the role of CD44 in DNA synthesis. Cultured vascular smooth muscle cells expressed CD44 and CD44-v6 at levels equal to or higher than those of the β1 and β3 integrins. In a rat carotid artery balloon injury model, CD44 and CD44-v6 mRNAs were upregulated in vascular smooth muscle cells after injury, and CD44 protein expression was greatest at the luminal edge of the growing neointima. CD44-expressing smooth muscle cells proliferated actively, and hyaluronic acid expression increased after injury in a temporal pattern similar to that of CD44. Through binding to hyaluronic acid, CD44 augmented DNA synthesis in cultured human and rat smooth muscle cells by 48±7.8 and 100±12.5%, respectively, an effect inhibited by an anti-CD44 antibody that blocked hyaluronate binding. These observations support a role for CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.

Original languageEnglish
Pages (from-to)596-603
Number of pages8
JournalJournal of Clinical Investigation
Volume97
Issue number3
Publication statusPublished - Feb 1 1996
Externally publishedYes

Fingerprint

Vascular Smooth Muscle
Smooth Muscle Myocytes
Wounds and Injuries
Hyaluronic Acid
Carotid Artery Injuries
Neointima
DNA
Proteoglycans
Integrins
Anti-Idiotypic Antibodies
Protein Isoforms
Cell Proliferation
Messenger RNA
Proteins

Keywords

  • carotid artery
  • DNA synthesis
  • hyaluronic acid
  • proteoglycans
  • smooth muscle cells

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jain, M., He, Q., Lee, W. S., Kashiki, S., Foster, L. C., Tsai, J. C., ... Haber, E. (1996). Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. Journal of Clinical Investigation, 97(3), 596-603.

Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. / Jain, Mukesh; He, Qi; Lee, Wen Sen; Kashiki, Saori; Foster, Lauren C.; Tsai, Jer Chia; Lee, Mu En; Haber, Edgar.

In: Journal of Clinical Investigation, Vol. 97, No. 3, 01.02.1996, p. 596-603.

Research output: Contribution to journalArticle

Jain, M, He, Q, Lee, WS, Kashiki, S, Foster, LC, Tsai, JC, Lee, ME & Haber, E 1996, 'Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury', Journal of Clinical Investigation, vol. 97, no. 3, pp. 596-603.
Jain, Mukesh ; He, Qi ; Lee, Wen Sen ; Kashiki, Saori ; Foster, Lauren C. ; Tsai, Jer Chia ; Lee, Mu En ; Haber, Edgar. / Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. In: Journal of Clinical Investigation. 1996 ; Vol. 97, No. 3. pp. 596-603.
@article{830a1cacf09a487aa7276529b77487cc,
title = "Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury",
abstract = "CD44, the principal receptor for hyaluronic acid, is a widely distributed cell surface proteoglycan involved in cellular activation, proliferation, and migration. These processes are also central to the vascular smooth muscle cell's response to arterial wall injury. We evaluated the expression of CD44 and its isoform, CD44-v6, on vascular smooth muscle cells in vitro and in vivo and assessed the role of CD44 in DNA synthesis. Cultured vascular smooth muscle cells expressed CD44 and CD44-v6 at levels equal to or higher than those of the β1 and β3 integrins. In a rat carotid artery balloon injury model, CD44 and CD44-v6 mRNAs were upregulated in vascular smooth muscle cells after injury, and CD44 protein expression was greatest at the luminal edge of the growing neointima. CD44-expressing smooth muscle cells proliferated actively, and hyaluronic acid expression increased after injury in a temporal pattern similar to that of CD44. Through binding to hyaluronic acid, CD44 augmented DNA synthesis in cultured human and rat smooth muscle cells by 48±7.8 and 100±12.5{\%}, respectively, an effect inhibited by an anti-CD44 antibody that blocked hyaluronate binding. These observations support a role for CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.",
keywords = "carotid artery, DNA synthesis, hyaluronic acid, proteoglycans, smooth muscle cells",
author = "Mukesh Jain and Qi He and Lee, {Wen Sen} and Saori Kashiki and Foster, {Lauren C.} and Tsai, {Jer Chia} and Lee, {Mu En} and Edgar Haber",
year = "1996",
month = "2",
day = "1",
language = "English",
volume = "97",
pages = "596--603",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury

AU - Jain, Mukesh

AU - He, Qi

AU - Lee, Wen Sen

AU - Kashiki, Saori

AU - Foster, Lauren C.

AU - Tsai, Jer Chia

AU - Lee, Mu En

AU - Haber, Edgar

PY - 1996/2/1

Y1 - 1996/2/1

N2 - CD44, the principal receptor for hyaluronic acid, is a widely distributed cell surface proteoglycan involved in cellular activation, proliferation, and migration. These processes are also central to the vascular smooth muscle cell's response to arterial wall injury. We evaluated the expression of CD44 and its isoform, CD44-v6, on vascular smooth muscle cells in vitro and in vivo and assessed the role of CD44 in DNA synthesis. Cultured vascular smooth muscle cells expressed CD44 and CD44-v6 at levels equal to or higher than those of the β1 and β3 integrins. In a rat carotid artery balloon injury model, CD44 and CD44-v6 mRNAs were upregulated in vascular smooth muscle cells after injury, and CD44 protein expression was greatest at the luminal edge of the growing neointima. CD44-expressing smooth muscle cells proliferated actively, and hyaluronic acid expression increased after injury in a temporal pattern similar to that of CD44. Through binding to hyaluronic acid, CD44 augmented DNA synthesis in cultured human and rat smooth muscle cells by 48±7.8 and 100±12.5%, respectively, an effect inhibited by an anti-CD44 antibody that blocked hyaluronate binding. These observations support a role for CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.

AB - CD44, the principal receptor for hyaluronic acid, is a widely distributed cell surface proteoglycan involved in cellular activation, proliferation, and migration. These processes are also central to the vascular smooth muscle cell's response to arterial wall injury. We evaluated the expression of CD44 and its isoform, CD44-v6, on vascular smooth muscle cells in vitro and in vivo and assessed the role of CD44 in DNA synthesis. Cultured vascular smooth muscle cells expressed CD44 and CD44-v6 at levels equal to or higher than those of the β1 and β3 integrins. In a rat carotid artery balloon injury model, CD44 and CD44-v6 mRNAs were upregulated in vascular smooth muscle cells after injury, and CD44 protein expression was greatest at the luminal edge of the growing neointima. CD44-expressing smooth muscle cells proliferated actively, and hyaluronic acid expression increased after injury in a temporal pattern similar to that of CD44. Through binding to hyaluronic acid, CD44 augmented DNA synthesis in cultured human and rat smooth muscle cells by 48±7.8 and 100±12.5%, respectively, an effect inhibited by an anti-CD44 antibody that blocked hyaluronate binding. These observations support a role for CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.

KW - carotid artery

KW - DNA synthesis

KW - hyaluronic acid

KW - proteoglycans

KW - smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0030062177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030062177&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 596

EP - 603

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -